(1 - 3 von 9
)
IMBRUVICA® (ibrutinib) Pooled Analysis Suggests Benefit ...AbbVie News Center
news.abbvie.com
AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, ...
sortiert nach Relevanz / Datum